Showing results (1241-1250 of 1,449) with videos related to

Sort By:
Pageof 145
Molecular Cancer Research : MCR|August 18, 2019
Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast CancerVidyalakshmi Sethunath, Huizhong Hu, Carmine De Angelis, et al.
Infectious Diseases and Therapy|April 16, 2023
Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital in South India: A Prospective Cohort StudyAbi Manesh, Chaitra Shankar, Mithun M George, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2019
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancerJ Veeraraghavan, C De Angelis, R Mao, et al.
Nature Cancer|June 28, 2022
Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancerKevin M Boehm, Emily A Aherne, Lora Ellenson, et al.
Infectious Diseases and Therapy|September 25, 2024
Combination Versus Monotherapy for Carbapenem-Resistant Acinetobacter Species Serious Infections: A Prospective IPTW Adjusted Cohort StudyAbi Manesh, Mithun Mohan George, Prasannakumar Palanikumar, et al.
Cancer Treatment Reviews|January 31, 2020
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysisFrancesco Schettini, Tomás Pascual, Benedetta Conte, et al.
Indian Journal of Medical Microbiology|December 12, 2022
India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-careBalaji Veeraraghavan, Yamuna Devi Bakthavatchalam, Abi Manesh, et al.
Cell Genomics|September 10, 2025
Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNAHeather A Parsons, Conor Messer, Katheryn Santos, et al.
Genome Research|June 6, 2014
A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samplesSamia N Naccache, Scot Federman, Narayanan Veeraraghavan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2023
A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast CancerJamunarani Veeraraghavan, Carolina Gutierrez, Carmine De Angelis, et al.
Pageof 145